bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026)

bioAffinity Technologies (BIAF) has reported Non-Current Assets for 6 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.16% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $13.0 million (down 15.93% YoY), while the FY2025 annual figure was $3.4 million, down 11.08% from the prior year.
• Non-Current Assets advanced to $3.6 million in Q1 2026 per BIAF's latest filing, from $3.4 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $4.2 million in Q4 2023 and bottomed at $7781.0 in Q3 2022.
• Historically, Non-Current Assets has averaged $2.8 million across 5 years, with a median of $3.6 million in 2026.
• Annual changes were most pronounced in 2023 — Non-Current Assets jumped 53611.03% — and 2025, when it decreased 26.73%.
• bioAffinity Technologies' Non-Current Assets stood at $220438.0 in 2022, then surged by 1827.44% to $4.2 million in 2023, then slipped by 10.13% to $3.8 million in 2024, then decreased by 11.08% to $3.4 million in 2025, then climbed by 6.13% to $3.6 million in 2026.
• Business Quant data shows BIAF's Non-Current Assets at $3.6 million in Q1 2026, $3.4 million in Q4 2025, and $2.9 million in Q3 2025.